NCT05848960 is a NA clinical trial of Hypercaloric, hyperproteic oral supplement in Sarcopenia, sponsored by Maimónides Biomedical Research Institute of Córdoba.

Who is sponsoring NCT05848960?

NCT05848960 is sponsored by Maimónides Biomedical Research Institute of Córdoba.

What drugs are being tested in NCT05848960?

Interventions in NCT05848960: Hypercaloric, hyperproteic oral supplement, Mediterranean diet.

What condition does NCT05848960 study?

NCT05848960 studies Sarcopenia.

Is NCT05848960 still recruiting?

NCT05848960 is currently completed. Last updated 6 May 2025.

Last reviewed 2025-05-06 · How we verify

NCT05848960

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mediterranean Diet and Nutritional Support in Heart Failure Sarcopenia

Completed NA Last updated 6 May 2025

What this trial tests

NA trial testing Hypercaloric, hyperproteic oral supplement in Sarcopenia in 50 participants. Completed in 30 July 2023.

Timeline

1 July 2021

Primary endpoint
1 July 2023

30 July 2023

Quick facts

Lead sponsor	Maimónides Biomedical Research Institute of Córdoba
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	50
Start date	1 July 2021
Primary completion	1 July 2023
Estimated completion	30 July 2023
Sites	1 location across Spain

Drugs / interventions tested

Hypercaloric, hyperproteic oral supplement
Mediterranean diet

Conditions studied

Sarcopenia — all drugs for Sarcopenia →

Sponsor

Maimónides Biomedical Research Institute of Córdoba

Who can join

Adults 18 to 90, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Heart failure (HF) is a chronic disease with an increasing incidence; it represents the final stage of multiple cardiac diseases and significantly affects the QoL of the patients. Its prevalence is about 26 million people in the world, especially in elderly. Sarcopenia has been directly associated with the presence of increased comorbidity in patients with HF. In this study the investigators aim to compare the clinical evolution of patients with HF after receiving nutritional support with Mediterranean diet alone or in combination with a hypercaloric, hyperproteic oral nutritional Supplement

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Mediterranean Diet, Vitamin D, and Hypercaloric, Hyperproteic Oral Supplements for Treating Sarcopenia in Patients with Heart Failure-A Randomized Clinical Trial.
Herrera-Martínez AD, Muñoz Jiménez C, López Aguilera J, Crespin MC, et al · · 2023 · cited 13× · PMID 38201939 · DOI 10.3390/nu16010110
Nutritional Support Reduces Circulating Cytokines in Patients with Heart Failure.
Herrera-Martínez AD, Jiménez CM, Romo AN, Aguilera JL, et al · · 2024 · cited 7× · PMID 38892570 · DOI 10.3390/nu16111637
Modulation of inflammasome components in patients with heart failure using oral nutritional supplements: investigating the molecular mechanisms beyond the clinical benefit.
Herrera-Martínez AD, Hermán-Sánchez N, G-García ME, Muñoz-Jiménez C, et al · · 2026 · PMID 41632188 · DOI 10.1007/s00394-025-03878-5

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting

Other Maimónides Biomedical Research Institute of Córdoba trials

Trials by the same sponsor.

NCT06783491 — Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Ad · Phase 3 · not yet recruiting
NCT07479303 — Vitamin D Status in Young Medical Residents · completed
NCT07178379 — Hysteroscopy Anesthesia for Relief of Pain · NA · not yet recruiting
NCT06712485 — Biomarkers in EV Associated With Marrow Adiposity in Anorexia · not yet recruiting
NCT06579846 — 12-Month Efficacy of Exercise and Cytisinicline for Tobacco Abstinence · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05848960 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Maimónides Biomedical Research Institute of Córdoba
Last refreshed: 6 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05848960.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing